Bio-Ker is a privately-owned, biopharmaceutical company, founded in 2003 as a spin-off from the pharmaceutical holding company Keryos. Bio-Ker’s activities comprise the research and development of therapeutic recombinant proteins, controlled-release protein delivery systems and therapeutic plasmid DNA vaccines.